“INVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION”. International Journal of Innovative Technologies in Social Science 2, no. 1(49) (March 6, 2026). Accessed March 17, 2026. https://rspublisher.org/index.php/ijitss/article/view/4659.